Diagnostics (HCV)

Hyaluronan Predicts Disease Severity in Patients with Cirrhosis

Published in Hepatitis Weekly, May 8th, 2000

A study conducted by researchers in France has shown that serum hyaluronan can be used as a prognostic marker to indicate the severity of complications in patients who are asymptomatic for hepatitis C virus (HCV) cirrhosis.

The results of this study were reported in a recent edition of the Journal of Hepatology by J. Guechot and associates ("Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis," J Hepatol, 2000;32(3):447-452).

"At entry, serum HA levels were measured in 91 patients (64 men, 27 women, 56 ± 11 years old) out of 103 who had asymptomatic, biopsy-proven cirrhosis," study authors said. These...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-05-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry